Atlas Trials

Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic Syndromes

Clinical trial NCT00997243 · TERMINATED

Trial details

NCT number
NCT00997243
Sponsor
Alison Walker
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
LeukemiaMyelodysplastic Syndromes
Start date
2009-11-01
Primary completion
2010-09-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.